Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updates to mortality on Mount Everest: 1921-2024.

The Journal of physiology·2026
Same author

Role of Atlantic multidecadal variability in modulating Arctic sea ice loss and wetting.

Science advances·2026
Same author

Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update.

Wilderness & environmental medicine·2024
Same author

Evolving relationship of Nares Strait ice arches on sea ice along the Strait and the North Water, the Arctic's most productive polynya.

Scientific reports·2023
Same author

Tracking westerly wind directions over Europe since the middle Holocene.

Nature communications·2022
Same author

Representation of Spatial Variability of the Water Fluxes over the Congo Basin Region.

Sensors (Basel, Switzerland)·2022

Related Experiment Videos

Mortality on Mount Everest, 1921-2006: descriptive study.

Paul G Firth1, Hui Zheng, Jeremy S Windsor

  • 1Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, MA 02114, USA. pfirth@partners.org

BMJ (Clinical Research Ed.)
|December 17, 2008
PubMed
Summary

Mount Everest climbing deaths are often due to trauma or high altitude illness, especially during descent. Fatigue and late summit times are early warning signs for climbers.

Related Experiment Videos

Area of Science:

  • Environmental Science
  • Human Physiology
  • Mountaineering Safety

Background:

  • Mount Everest expeditions have a long history, attracting both professional climbers and support staff (Sherpas).
  • Understanding mortality patterns is crucial for improving safety on high-altitude expeditions.

Purpose of the Study:

  • To analyze mortality trends among Mount Everest climbers over an 86-year period (1921-2006).
  • To identify causes and circumstances of death for both climbers and Sherpas.

Main Methods:

  • A descriptive study analyzing data from 14,138 mountaineers (8,030 climbers, 6,108 Sherpas) on Mount Everest.
  • Examined circumstances of deaths, including cause (trauma, non-traumatic, disappearance) and timing during the expedition.

Main Results:

  • Overall mortality rate above base camp was 1.3%.
  • Deaths were attributed to trauma (47%), non-traumatic causes (21%), and disappearances (11%).
  • The death rate during descent was significantly higher for climbers than Sherpas (2.7% vs. 0.4%).
  • Late summit times and symptoms like fatigue and cognitive changes were associated with higher mortality.

Conclusions:

  • High-altitude cerebral edema symptoms are common during descent from Mount Everest.
  • Profound fatigue and delayed summit ascent times are critical indicators of increased mortality risk.